Overview
-
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
₹39.34
▼ 0.19
(0.48%)
07 Oct 2026
| Instrument Name | Watchlist | Investment Date | % Holding | No of Units | Value (₹ Cr) | Asset Type | Industry Name |
|---|---|---|---|---|---|---|---|
 Torrent Pharmaceuti... | 31 Aug 2026 | 9.57% | 2,08,262 | ₹105.51 Cr | Equity | Pharmaceuticals | |
 Sun Pharmaceutical ... | 31 Aug 2026 | 9.19% | 5,10,815 | ₹101.39 Cr | Equity | Pharmaceuticals | |
 Apollo Hospitals En... | 31 Aug 2026 | 6.85% | 84,936 | ₹75.58 Cr | Equity | Healthcare | |
 Cipla Ltd | 31 Aug 2026 | 5.16% | 4,04,098 | ₹56.95 Cr | Equity | Pharmaceuticals | |
| Aurobindo Pharma Ltd | 31 Aug 2026 | 4.53% | 2,91,254 | ₹50.01 Cr | Equity | Pharmaceuticals | |
| Ajanta Pharma Ltd | 31 Aug 2026 | 4.22% | 1,29,312 | ₹46.58 Cr | Equity | Pharmaceuticals | |
| Sai Life Sciences Ltd | 31 Aug 2026 | 4.20% | 3,17,245 | ₹46.31 Cr | Equity | Pharmaceuticals | |
| TREPS | 31 Aug 2026 | 3.85% | 0 | ₹42.47 Cr | Reverse Repo | Debt Others | |
 Mankind Pharma Ltd | 31 Aug 2026 | 3.41% | 1,55,574 | ₹37.64 Cr | Equity | Pharmaceuticals | |
 Lupin Ltd | 31 Aug 2026 | 3.10% | 1,56,214 | ₹34.19 Cr | Equity | Pharmaceuticals |
Funds in the same category by AUM
| Company | Watchlist | Sector | Activity | Investment Date | % Holding | Market Value | Shares | Asset Type | Rating |
|---|---|---|---|---|---|---|---|---|---|
 Natco Pharma Ltd | Pharmaceuticals -... | Bought | 31 Aug 2026 | 0.92% | ₹10.10 Cr | 1,20,000 | Equity | EQUITY | |
| TREPS | Debt Others | Bought | 31 Jul 2026 | 2.30% | ₹24.67 Cr | 0 | Reverse Repo | UR / N.A. | |
| Manipal Health Ente... | Hospitals / Medic... | Bought | 31 Jul 2026 | 0.89% | ₹9.58 Cr | 1,62,425 | Equity | EQUITY | |
 J B Chemicals & Pha... | Pharmaceuticals -... | Sold | 30 Jun 2026 | 4.71% | ₹47.64 Cr | 2,07,484 | Equity | EQUITY | |
| C C I | Debt Others | Sold | 30 Jun 2026 | 2.26% | ₹22.82 Cr | 0 | Reverse Repo | UR / N.A. |
You can invest in Aditya Birla SL Pharma & Healthcare Fund - Dir (G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹1,000 and the minimum SIP amount is ₹10.
The latest NAV of Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is ₹39.34.
Aditya Birla SL Pharma & Healthcare Fund - Dir (G) manages assets worth ₹1,102.73 Cr.
The expense ratio of Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is 1.07%.
The exit load applicable on Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is For redemption / switch-out of units on or before 30 days from the date of allotment: 1% of applicable NAV. For redemption / switch-out of units after 30 days from the date of allotment: : Nil..
As per the riskometer, Aditya Birla SL Pharma & Healthcare Fund - Dir (G) carries Very High risk.
Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is managed by Aditya Birla Sun Life Mutual Fund.
Aditya Birla SL Pharma & Healthcare Fund - Dir (G) belongs to the Sectoral Fund category.
Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is benchmarked against the BSE Healthcare TRI.
Aditya Birla SL Pharma & Healthcare Fund - Dir (G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
Aditya Birla SL Pharma & Healthcare Fund - Dir (G) was launched on 11 Jul 2019.
After the initial investment, you can invest in Aditya Birla SL Pharma & Healthcare Fund - Dir (G) in further multiples of ₹1,000.
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes' objectives will be achieved.
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes' objectives will be achieved.
11 Jul 2019
₹1,102.73 Cr
₹39.34
₹10
₹1,000
Very High
1.07%
15.19
0.65
0.93
4.50
0.56
0.12
0.18
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Calendar year return from the first period shown through each year.
Funds in the same category by AUM
| Fund | Watchlist | AMC | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
 ICICI Pru Technology Fund... | ICICI Prudential Mutual Fund | ₹193.36 | ₹13,660.98 Cr | 1.21% | -9.90% | 4.62% | 2.36% | |
 HDFC Defence Fund - Direc... | HDFC Mutual Fund | ₹30.47 | ₹11,477.59 Cr | 0.89% | 21.28% | 36.36% | — | |
| ICICI Pru Banking & Finan... | ICICI Prudential Mutual Fund | ₹143.81 | ₹11,330.58 Cr | 1.25% | -5.10% | 9.25% | 8.99% | |
 SBI Banking & Financial S... | SBI Mutual Fund | ₹47.34 | ₹10,872.95 Cr | 1.19% | -3.16% | 14.53% | 11.61% | |
 Tata Digital India Fund -... | Tata Mutual Fund | ₹45.84 | ₹10,322.02 Cr | 0.67% | -13.60% | 3.53% | 2.29% | |
| Aditya Birla SL Pharma & ... | Aditya Birla Sun Life Mutua... | ₹39.34 | ₹1,102.73 Cr | 1.07% | 16.16% | 20.47% | 14.07% |
| Fund | 1Y | 3Y | Expense Ratio | Fund Size | Alpha | Sharpe | Risk | |
|---|---|---|---|---|---|---|---|---|
 Nippon India Pharma Fund - Di... | 11.40% | 18.02% | 1.00% | ₹9,479.08 Cr | 13.04 | 0.82 | Very High | |
| SBI Healthcare Opportunities ... | 19.06% | 23.09% | 1.01% | ₹5,796.42 Cr | 17.40 | 1.13 | Very High | |
 Mirae Asset Healthcare Fund -... | 19.10% | 22.41% | 0.62% | ₹3,555.18 Cr | 16.59 | 0.97 | Very High | |
| Tata India Pharma & Healthcar... | 6.95% | 18.83% | 1.07% | ₹1,565.28 Cr | 14.08 | 0.80 | Very High | |
 UTI-Healthcare Fund - Direct (G) | 15.76% | 23.01% | 1.34% | ₹1,429.84 Cr | 17.45 | 1.03 | Very High | |
| Aditya Birla SL Pharma & Heal... | 16.16% | 20.47% | 1.07% | ₹1,102.73 Cr | 15.19 | 0.93 | Very High | |
 WhiteOak Capital Pharma and H... | 21.66% | — | 1.09% | ₹902.24 Cr | 19.56 | 1.03 | Very High |